MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared drug-delivery device, is proud to announce a presentation of a new pre-clinical clinical data abstract at the upcoming Society of Surgical Oncology (SSO) 2025 Annual Meeting. The abstract, titled “Pharmacodynamics of Intra-arterial vs. Intravenous Gemcitabine in Locally.
The S&P 500 Index has shown a long-term bullish trend, with significant returns since 1980, despite occasional corrections. ProShares Ultra S&P500 ETF offers leveraged exposure to the S&P 500, magnifying gains but also increasing risk due to time decay. Lower interest rates, potential tax cuts, and regulatory changes under the Trump administration could support higher stock prices in 2025.
Leveraged ETFs like ProShares Ultra S&P500 (SSO) amplify returns both on the upside and on the downside. SSO aims to achieve 2x the daily performance of the S&P 500 but fails to maintain this over extended periods due to beta slippage effects. With current high P/E levels, the S&P 500 is overvalued, suggesting a potential pull-back, making leveraged funds like SSO risky.
![]() SSO 6 months ago | Other | $0.24 Per Share |
![]() SSO 9 months ago Paid | Quarterly | $0.17 Per Share |
![]() SSO 26 Jun 2024 Paid | Quarterly | $0.19 Per Share |
![]() SSO 20 Mar 2024 Paid | Quarterly | $0.18 Per Share |
![]() SSO 20 Dec 2023 Paid | Quarterly | $0.12 Per Share |
![]() SSO 6 months ago | Other | $0.24 Per Share |
![]() SSO 9 months ago Paid | Quarterly | $0.17 Per Share |
![]() SSO 26 Jun 2024 Paid | Quarterly | $0.19 Per Share |
![]() SSO 20 Mar 2024 Paid | Quarterly | $0.18 Per Share |
![]() SSO 20 Dec 2023 Paid | Quarterly | $0.12 Per Share |
ARCA Exchange | US Country |
The described company operates as an investment fund, focusing on leveraging financial instruments to generate daily returns that align with its Daily Target. The fund’s investment strategy is anchored around an index that serves as a benchmark for large-cap U.S. stock market performance. This index is comprehensive, incorporating 500 U.S. operating companies and real estate investment trusts (REITs), ensuring a wide exposure to the American economy's significant sectors. The selection process for the index involves thorough criteria, including liquidity, price, market capitalization, financial viability, and public float, ensuring only the most robust and reliable entities are included. Despite its extensive market coverage, the fund is categorized as non-diversified, indicating a concentrated investment approach that may focus on specific sectors or financial instruments to achieve its objectives.
This investment strategy is at the core of the fund's operation, where the fund invests in a variety of financial instruments that, when combined, are expected to produce daily returns in alignment with the fund's pre-determined Daily Target. This approach is designed for investors looking for consistent, short-term gains, leveraging the daily fluctuations in the market.
The fund employs a market strategy that focuses on large-cap U.S. stocks, guided by a comprehensive, float-adjusted, market capitalization-weighted index of 500 U.S. operating companies and real estate investment trusts. This index, reflecting significant portions of the U.S. economy, offers a balanced exposure to investors seeking growth and stability in large-cap stocks and real estate investments in the thriving U.S. market. The selection process for entities within this index is rigorous, factoring in liquidity, market capitalization, financial viability, and public float, ensuring investments are made in financially sound and stable companies and REITs.